中泰化学（002092）公告，控股子公司中泰新材料投资建设的资源化综合利用制甲醇升级示范项目于 2025年4月顺利完成中交，5月试生产成功，并产出合格甲醇产品。近期项目逐步提产，生产全流程正式 贯通，目前已全面投产。中泰新材料余热发电装置一次性并网发电成功，通过回收甲醇生产过程中的高 温余热，驱动汽轮机组发电，实现能源的梯级利用，降低了用电成本。甲醇项目全面投产后，生产成本 将进一步降低，有利于公司形成规模优势、产业链优势和成本优势，提升市场竞争力。 ...

Group 1: Company Initiatives - China National Offshore Oil Corporation (CNOOC) is implementing a comprehensive green transformation across its operations, focusing on ecological restoration and sustainable development [1][5] - The company has launched multiple solar photovoltaic projects, including a 1.88 MW installation at the Basuo Port, generating over 2 million kWh annually, and a planned 3.89 MW expansion [2][4] - CNOOC's Daguikou Company has transformed its rooftop into a "roof power plant" with 17,575 solar panels, producing 3.6 million kWh of clean energy and reducing carbon emissions by nearly 2,000 tons [6][8] Group 2: Environmental Impact - The initiatives at Basuo Port are expected to reduce carbon emissions by over 10,000 tons annually through the transition to LNG fueling for vehicles and the implementation of electric loading systems [4][5] - The Daguikou Company's solar project has led to a 12% reduction in carbon footprint intensity, showcasing the effectiveness of integrating renewable energy into operations [8][12] - CNOOC's efforts in VOCs treatment at the Fudao Company have achieved a removal efficiency of over 97%, significantly lowering harmful emissions [9][11] Group 3: Ecological Restoration - CNOOC's Huhe Company has successfully rehabilitated 19 hectares of abandoned mining pits into thriving ecological forests, utilizing waste materials from production processes [15][17] - The collaboration between Huhe Company and local government has resulted in a cost-effective solution for waste disposal while enhancing local environmental quality [16][17] - The ecological restoration efforts have transformed previously unusable land into recreational areas for the community, demonstrating the company's commitment to sustainable practices [17][19]

证券代码：600426 证券简称：华鲁恒升 公告编号：临2025-037 A股每股现金红利0.30元。 本次利润分配方案经公司2025年4月29日的2024年年度股东大会审议通过。 山东华鲁恒升化工股份有限公司 2024年年度权益分派实施公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 每股分配比例 二、分配方案 1.发放年度：2024年年度 2.分派对象： 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任公司上海分公司（以下简 称"中国结算上海分公司"）登记在册的本公司全体股东。公司股票回购专用账户所持有的公司股份不参 与本次利润分配。 3.差异化分红送转方案： （1）差异化分红方案 本次利润分配以公司总股本2,123,219,998股扣减公司回购账户2,300,000股，即2,120,919,998股为基数， 向全体股东每10股派发现金红利3.00元（含税），总计向全体股东派发现金红利636,275,999.40元（含 税）。 （2）差异化分红除权除息的处理依据及计算公式 依据《上 ...

Core Viewpoint - The company is transitioning from pearl materials to high-end titanium dioxide production, leveraging innovative extraction methods to tap into a significantly larger market opportunity, thus creating a strong second growth curve [2][3][4]. Group 1: Company Strategy and Innovation - The company has developed the world's first extraction method for chloride titanium dioxide, positioning itself as a key player in the high-end titanium dioxide market, which is substantially larger than the pearl materials market [3][4]. - The market size ratio between pearl materials and titanium dioxide is approximately 1:100, indicating that while pearl materials demand is around 100,000 tons, titanium dioxide demand is nearly 10 million tons [3]. - The company aims to enhance its production capabilities and market presence by focusing on efficient and environmentally friendly technologies [2][4]. Group 2: Research and Development - The development of the extraction method took 13 years, highlighting the challenges faced during the R&D process, which exceeded initial expectations in terms of time and resources [6]. - The company’s R&D efforts have resulted in the only third-generation titanium dioxide production technology globally, attracting interest from numerous international firms for potential collaboration [6][7]. Group 3: Market Position and Future Plans - The company holds a leading position in the pearl materials market, with a significant overlap in customer bases for both pearl and titanium dioxide products, covering 60% to 70% of global titanium dioxide demand customers [4][7]. - Future goals include achieving production balance for a 1 million ton titanium dioxide project, advancing the Zhangzhou vanadium-titanium project, and increasing investments in mining operations [8]. - The company plans to develop high-value-added products and enhance its product offerings in cosmetics and food-grade applications, aiming to increase the proportion of high-end product sales from 50% to 75% [7][8].

近日该股表现 | 日期 | 当日涨跌幅（%） | 换手率（%） | 主力资金净流入（万元） | | --- | --- | --- | --- | | 2025.06.20 | -10.07 | 9.08 | 272.34 | | 2025.06.19 | 3.55 | 13.64 | -10938.59 | | 2025.06.18 | 9.90 | 5.64 | 7202.11 | | 2025.06.17 | -5.65 | 7.93 | 236.80 | | 2025.06.16 | 8.24 | 11.08 | -8731.22 | | 2025.06.13 | 9.94 | 3.79 | 2939.10 | | 2025.06.12 | -1.16 | 0.52 | -80.05 | | 2025.06.11 | 0.58 | 0.50 | -81.19 | | 2025.06.10 | -0.29 | 0.70 | -95.78 | | 2025.06.09 | 1.77 | 0.72 | 630.76 | 注：本文系新闻报道，不构成投资建议，股市有风险，投资需谨慎。 （文章来源：证券时报网） ...

Core Viewpoint - The company has adjusted its 2024 restricted stock incentive plan, including changes to the repurchase price of restricted stocks due to dividend distribution and performance assessments of incentive targets [1][4][6]. Group 1: Approval Process - The company held multiple board and supervisory meetings to approve the 2024 restricted stock incentive plan and its related documents, including the draft and management measures [1][2][3]. - The supervisory board confirmed the list of incentive targets and the public announcement of the plan was made without objections during the designated period [2][3]. Group 2: Adjustment Details - The adjustment was necessitated by the company's decision to distribute cash dividends of RMB 1.25 per share, totaling RMB 13.8 million, which was implemented on May 26, 2025 [5]. - The repurchase price of the restricted stocks was recalculated to account for the dividend, resulting in an adjusted price of RMB 7.735 per share [5][6]. Group 3: Impact on the Company - The adjustment of the repurchase price aligns with relevant regulations and will not materially affect the company's financial status or operational results [6][7]. - The supervisory board and legal opinions confirm that the adjustments comply with applicable laws and regulations, ensuring no harm to shareholder interests [7].

Group 1 - The company announced a share repurchase plan with a total expected amount between 75 million and 150 million RMB, with a repurchase period from September 20, 2024, to September 19, 2025 [1] - The repurchase is intended for employee stock ownership plans or equity incentives, with a maximum repurchase price set at 5.00 RMB per share [1] - As of June 20, 2025, the company has repurchased a total of 20,592,200 shares, accounting for 1.001% of the total share capital, with a total expenditure of 80,457,115.00 RMB [3] Group 2 - The company held a board meeting on October 18, 2024, to change the purpose of the repurchased shares from solely for employee stock ownership plans to include equity incentives [2] - Following the distribution of cash dividends, the maximum repurchase price was adjusted from 5.00 RMB to 4.99 RMB per share on January 24, 2025, and further adjusted to 4.96 RMB on June 17, 2025 [2][3] - The company will continue to make repurchase decisions based on market conditions and will fulfill its information disclosure obligations regarding the progress of the share repurchase [4]

| | | 公告编号：2025-050 | | --- | --- | --- | | 证券代码：605020 | 证券简称：永和股份 | | 债券代码：111007 债券简称：永和转债 浙江永和制冷股份有限公司 关于调整股票期权行权价格的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 由 22.60 元/股调整为 22.35 元/股。现对有关事项说明如下： 一、2021 年股票期权与限制性股票激励计划已履行的审议程序 浙江永和制冷股份有限公司（以下简称"公司"）于 2025 年 6 月 19 日召开 第四届董事会第十九次会议及第四届监事会第十六次会议，审议通过了《关于调 整股票期权行权价格的议案》，同意将公司首次及预留授予部分股票期权行权价格 <浙江永和制冷股份有限公司 ensp="ensp" 年股票期权与限制性股票激励计划="年股票期权与限制性股 票激励计划" 草案="草案"> 及其 摘要的议案》《关于 <浙江永和制冷股份有限公司 ensp="ensp" 年股票期权与限制性股票激="年股票期 权与限制性股票激"> ...

Core Viewpoint - The new FDA regulation mandating the addition of taurine in infant formula and pet food has significantly impacted the global food industry, leading to a surge in demand and prices for taurine, with Chinese company Yong'an Pharmaceutical becoming a key player in this market [1][3]. Group 1: Market Dynamics - The price of food-grade taurine skyrocketed by 75% within a month, with quotes reaching 25,000 yuan per ton, compared to 13,000 yuan per ton in March 2025 [3]. - The global taurine market is characterized by a supply-demand imbalance, with an annual demand of approximately 160,000 tons and existing production capacity of only 140,000 tons, resulting in a supply gap of about 20,000 tons [9]. Group 2: Company Positioning - Yong'an Pharmaceutical holds over 90% of the global taurine production capacity and is the only company with FDA and EFSA certifications, allowing it to charge a premium price of 82,000 USD per ton for its pharmaceutical-grade taurine [10]. - The company has seen a 120% year-on-year increase in exports of its pharmaceutical-grade products to the US and EU markets [10]. Group 3: Industry Trends - The demand for taurine is driven by various applications, including functional beverages and high-end pet food, with the young consumer demographic in China showing a 20% annual growth in taurine consumption [5]. - The pet food market has seen a penetration rate of over 35% for premium products, with some cat food containing taurine levels ten times higher than those for humans [5]. Group 4: Competitive Landscape - The taurine industry is highly concentrated, with three main players: Yong'an Pharmaceutical, Shengyuan Environmental Protection, and New Hecheng, which together dominate the market [9]. - Shengyuan Environmental Protection is set to launch a new 40,000-ton food-grade taurine project in the second half of 2025, potentially altering the competitive dynamics in the mid-to-low-end market [13].

证券代码：000912 证券简称：泸天化 公告编号：2025-040 四川泸天化股份有限公司 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误导性 陈述或重大遗漏。 四川泸天化股份有限公司（以下简称"公司"）于2024年6月20日召开2023 年度股东大会，审议通过了《四川泸天化股份有限公司回购股份方案》，同意公 司使用自有资金以集中竞价交易方式回购公司部分股份，回购资金总额不低于人 民币8,000万元（含），不超过人民币15,000万元（含），回购价格不超过人民 币6.09元/股（含本数），本次回购股份将用于股权激励。本次回购股份的实施 期限自2023年度股东大会审议通过回购股份方案之日起12个月内（2025年6月19 日止）。具体回购股份的金额和数量以回购结束时实际回购的金额和股份数量为 准。公司已在中国证券登记结算有限责任公司深圳分公司开立股份回购专用证券 账户并披露了《回购报告书》。 截至本公告披露日，公司本次回购股份计划已实施完毕。根据《上市公司股 份回购规则》《深圳证券交易所上市公司自律监管指引第 9 号——回购股份》 等相关规定，现将公司本次回购结果公告如下： 一、回购股份 ...